Simvastatin/Ezetimibe Not Beneficial in Alopecia Areata

This article originally appeared here.
Share this content:
Simvastatin/Ezetimibe Not Beneficial in Alopecia Areata
Simvastatin/Ezetimibe Not Beneficial in Alopecia Areata

WEDNESDAY, April 27, 2016 (HealthDay News) -- Simvastatin/ezetimibe does not appear to be beneficial for severe alopecia areata (AA) in a sample of 20 patients, according to a letter to the editor published in the May issue of the Journal of the American Academy of Dermatology.

Camilla Loi, M.D., from the University of Bologna in Italy, and colleagues present the results of a prospective study with simvastatin/ezetimibe in 20 patients older than 18 years with AA totalis/universalis or involvement of the scalp >70 percent, who had previously undergone one or more treatments. For six months, patients were given simvastatin/ezetimibe 40 mg/10 mg daily. Patients were evaluated every eight weeks and underwent global photography and blood tests together with assessment of the tolerability of the drugs.

The researchers found that 85 percent of patients had completed the study at the end of the six-month treatment period. Eighty-two percent of patients (14 of 17) had no hair regrowth; 12 and 6 percent had a transient diffuse hair regrowth followed by total hair loss in one month during the treatment period and a patchy hair regrowth of pigmented hair, respectively. Three patients had side effects, including mild headache or muscle cramps, which did not interrupt treatment.

"In conclusion, we did not obtain any result with simvastatin/ezetimibe therapy in severe AA," the authors write. "More studies with a control group, a higher number of patients, and a longer duration of therapy are necessary to verify the real role of simvastatin/ ezetimibe in the treatment of AA."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Pharmacists Should Counsel Patients Fasting for Ramadan

Pharmacists Should Counsel Patients Fasting for Ramadan

Pharmacists can suggest adjustments for meds taken several times per day, those affected by food intake

AUA: Many Have Unused Opioids After Urologic Procedures

AUA: Many Have Unused Opioids After Urologic Procedures

Patients use just over half of initial prescription; highest percentage of unused meds for cystectomy

Over Half of Young Adult Smoke Volume Exposure From Hookahs

Over Half of Young Adult Smoke Volume Exposure ...

Toxicant exposure to tar, carbon monoxide, nicotine lower, but still substantial, compared to cigarettes

is free, fast, and customized just for you!

Already a member?

Sign In Now »